Like you know something isn’t right with your health, but the doctor either dismissed your concerns or prescribed a ...

Atopic dermatitis, a chronic skin condition, is common in children and requires treatment to minimise frequent flares. Dr Ker ...

Adbry ® (tralokinumab-ldrm) 300 mg/2 mL single-dose autoinjector in the United States. Adbry is currently indicated in the U.S. for patients 12 years and older with moderate-to-severe atopic ...

Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype Following recent ...

Under the terms of the deal—which is expected to close ... With Vtama's success in relieving itching, Dermavant eyes FDA ...

Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for the treatment of adults and ...

Amgen said on Tuesday its experimental drug, rocatinlimab, met the main goals in a late stage study testing it as a treatment ...

VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an additional ...

Often thought of as simple redness of the skin, eczema is a chronic inflammatory skin condition that most often results in ...

Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission compared to placebo, consistent with improvements seen in ...

Pfizer says the drugs seem to have an impact on itch – often cited as the most bothersome symptom in atopic dermatitis. Aurion Biotech has launched its cell therapy Vyznova for serious eye ...

It is not known if DUPIXENT is safe and effective in children with atopic dermatitis under 6 months of age ... including if you: have eye problems. have a parasitic (helminth) infection.